SPA
DXCM icon

Sherbrooke Park Advisers’s DexCom DXCM Stock Holding History

Sherbrooke Park Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,695
Closed -$1.06M – 305
2025
Q3 		$1.06M Buy
+15,695
New +$1.24M 0.49% 27
2024
Q4 		– Sell
-11,100
Closed -$744K – 869
2024
Q3 		$744K Buy
11,100
+3,612
+48% +$297K 0.17% 163
2024
Q2 		$849K Buy
7,488
+3,989
+114% +$504K 0.15% 219
2024
Q1 		$485K Buy
+3,499
New +$440K 0.09% 368
2023
Q4 		– Sell
-11,648
Closed -$1.09M – 527
2023
Q3 		$1.09M Buy
+11,648
New +$1.31M 0.34% 92
2023
Q2 		– Sell
-2,200
Closed -$256K – 350
2023
Q1 		$256K Buy
+2,200
New +$246K 0.39% 124

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sherbrooke Park Advisers's DXCM Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of DexCom (DXCM) in Q4 2025, closing a stake of 15,695 shares — an estimated $1.06M sold.

Sherbrooke Park Advisers first reported a position in DXCM in Q1 2023 and held it in 6 quarters. The position peaked at $1.09M in Q3 2023. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 15,695 DexCom shares in Q4 2025, an estimated $1.06M.
  • Sherbrooke Park Advisers first reported a position in DexCom in Q1 2023 and held it in 6 quarters.
  • Sherbrooke Park Advisers's DexCom position peaked at $1.09M in Q3 2023.
  • 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.